SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Month: December 2016

    Fovista® Fails Final Test For Wet AMD Treatment

    Posted on December 21, 2016April 9, 2021 by droberts
  • December 21, 2016

    Fovista® Fails Final Test For Wet AMD Treatment

    Fovista®, a once-promising experimental drug for treatment of wet macular degeneration, has failed to show positive results in Phase 3 trials. This is surprising, since, on June 14, 2012, Ophthotech Corporation reported a 62% higher relative visual benefit when Fovista (1.5 mg) was used in combination with Lucentis in Phase 2b clinical trials. Based upon those […]

      Also posted in
    • Latest News
    • Research and Developments
  • Photobiomodulation—A New Treatment For Dry AMD?

    Posted on December 6, 2016 by droberts
  • December 6, 2016

    Photobiomodulation—A New Treatment For Dry AMD?

    (Updated 11/8/17) A new non-invasive technology from LumiThera Inc. may help improve vision in  people with dry age-related macular degeneration. Photobiomodulation involves exposure of the retina to light from diodes emitting red, yellow, and infrared wavelengths. Researchers in Switzerland and Toronto recently found that treating eyes three times a week for three weeks improved best […]

      Also posted in
    • Latest News
    • Research and Developments
  • More Responders Needed for AMD Survey

    Posted on December 6, 2016 by droberts
  • December 6, 2016

    More Responders Needed for AMD Survey

    The Cochrane Eyes and Vision US Satellite (CEV@US), located at The Johns Hopkins Bloomberg School of Public Health (JHBSPH) is conducting an important survey to identify research priorities for age-related macular degeneration (AMD). Their previous request for participants in the survey has yielded 35 responses so far, but at least 50 are needed. The survey will take […]

      Also posted in
    • Latest News
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.